Drug Profile
CB 003
Alternative Names: CB-003; GC enriched liposomal vinorelbine - Ceronco Biosciences; Glucosylceramide enriched liposomal vinorelbine - Ceronco Biosciences; Vinorelbine liposomal - Ceronco BiosciencesLatest Information Update: 05 Nov 2021
Price :
$50
*
At a glance
- Originator Ceronco Biosciences
- Class Antineoplastics; Small molecules; Vinca alkaloids
- Mechanism of Action Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for preclinical development in Cancer in Netherlands
- 26 Oct 2016 Preclinical trials in Cancer in Netherlands (unspecified route)